Clinical Trial Details


Back to Clinical Trials Database

Phase II study on Gemcitabine in Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck

Study documentation Publications

Trial Status All trial activities ended
Dates Date of activation: 02-Apr-2001
Date Step1 close: 25-Apr-2003
Data management at EORTC Yes
Design Phase 2
Randomized open
Targeted Sample size EORTC Groups: 29
Treatment Gemcitabine
Study Staff
Type of cancer
Participating groups EORTC Head and Neck Cancer Group
Participating centers
Protocol summary
NCT number NCT00017498